TY  - JOUR

T1  - The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre

JO  - Seizure

PY  - 2020/07/01

AU  - Davies P

AU  - Reuber M

AU  - Grunewald R

AU  - Howell S

AU  - Dickson J

AU  - Dennis G

AU  - Shanmugarajah P

AU  - Tsironis T

AU  - Brockington A

ED  - 

DO  - DOI: 10.1016/j.seizure.2020.03.015

PB  - Elsevier BV

VL  - 79

SP  - 8

EP  - 13

Y2  - 2024/09/19

ER  -